{"id":20973,"date":"2023-02-28T13:00:00","date_gmt":"2023-02-28T12:00:00","guid":{"rendered":"https:\/\/qlinea.com\/mfn_news\/q-linea-presenterar-pa-stockholm-corporate-finance-15e-life-science-kapitalmarknadsdagar\/"},"modified":"2023-02-28T13:05:06","modified_gmt":"2023-02-28T12:05:06","slug":"q-linea-presenterar-pa-stockholm-corporate-finance-15e-life-science-kapitalmarknadsdagar","status":"publish","type":"mfn_news","link":"https:\/\/qlinea.com\/sv\/mfn_news\/q-linea-presenterar-pa-stockholm-corporate-finance-15e-life-science-kapitalmarknadsdagar\/","title":{"rendered":"Q-linea presenterar p\u00e5 Stockholm Corporate Finance 15:e Life Science Kapitalmarknadsdagar"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Q-linea deltar p\u00e5 Stockholm Corporate Finance 15:e Life Science Kapitalmarknadsdagar den 8 &#8211; 9 mars 2023 p\u00e5 IVA konferenscenter i Stockholm. VD Jonas Jarvius presenterar den 8 mars kl. 9:00 \u2013 9:30 den senaste utvecklingen och framtiden f\u00f6r bolaget.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Stockholm Corporate Finance arrangerar kapitalmarknadsdagarna f\u00f6r femtonde \u00e5ret i rad i samarbete med Financial Hearings och Infront Direkt Studios som \u00e4r en frist\u00e5ende del av Nyhetsbyr\u00e5n Direkt. Om du vill anm\u00e4la dig som deltagare till kapitalmarknadsdagen s\u00e5 anv\u00e4nd denna l\u00e4nk, <a href=\"https:\/\/www.lyyti.fi\/reg\/Stockholm_Corporate_Finance_15e_Life_Science_Seminarium_den_89_mars_2023_6927\" rel=\"noopener\" target=\"_blank\">Stockholm Corporate Finance 15e Life Science Seminarium den 8-9 mars 2023 (lyyti.fi)<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-828219978778\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information, v\u00e4nligen kontakta:<\/strong><\/p>\n<hr>\n<p>Jonas Jarvius, CEO, Q-linea AB<br \/>\n<a href=\"mailto:Jonas&#46;Jarvius&#64;qli&#110;&#101;&#97;&#46;&#99;&#111;&#109;\" rel=\"noopener\" target=\"_blank\">&#x4a;&#x6f;&#x6e;&#x61;&#115;&#46;&#74;&#97;rvi&#x75;&#x73;&#x40;&#x71;&#x6c;&#105;&#110;&#101;a&#46;c&#x6f;&#x6d;<\/a><br \/>\n+46 (0) 70-323 77 60<\/p>\n<p>Anders Lundin, CFO, Q-linea AB<br \/>\n<a href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x41;&#x6e;de&#114;&#115;&#46;&#x4c;&#x75;&#x6e;&#x64;in&#64;&#113;&#108;&#x69;&#x6e;&#x65;&#x61;&#46;c&#111;&#109;\" rel=\"noopener\" target=\"_blank\">&#x41;&#x6e;&#100;e&#x72;&#x73;&#46;&#76;u&#x6e;&#x64;&#105;&#110;&#64;&#x71;&#x6c;&#105;ne&#x61;&#x2e;&#99;o&#x6d;<\/a><br \/>\n+46 (0) 70-600 15 20<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-2048cb62925b\">\n<p><strong class=\"mfn-heading-1\">Om Q-linea<\/strong><\/p>\n<hr>\n<p>Q-linea \u00e4r ett innovativt infektionsdiagnostikbolag vars fokus \u00e4r utveckling av instrument och f\u00f6rbrukningsartiklar f\u00f6r snabb och p\u00e5litlig infektionsdiagnostik. V\u00e5r vision \u00e4r att hj\u00e4lpa till att r\u00e4dda liv genom att s\u00e4kerst\u00e4lla att antibiotika fortfarande \u00e4r en effektiv behandling f\u00f6r kommande generationer. Q-linea utvecklar och levererar l\u00f6sningar f\u00f6r v\u00e5rdgivare som p\u00e5 kortast m\u00f6jliga tid kan diagnostisera och behandla infektionssjukdomar. Bolagets ledande produkt ASTar\u00ae \u00e4r ett helautomatiskt instrument f\u00f6r test av antibiotikaresistens (AST), vilket ger en k\u00e4nslighetsprofil inom sex timmar direkt fr\u00e5n en positiv blodkultur. F\u00f6r mer information, bes\u00f6k g\u00e4rna <a href=\"http:\/\/www.qlinea.com.\" rel=\"noopener\" target=\"_blank\">www.qlinea.com.<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/99b595e5-c54c-4206-81cc-4653b6c5c244\/q-linea-presenterar-pa-stockholm-corporate-finance-15-e-life-science-kapitalmarknadsdagar.pdf\" rel=\"noopener\" target=\"_blank\">Q-linea presenterar p\u00e5 Stockholm Corporate Finance 15:e Life Science Kapitalmarknadsdagar<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Q-linea deltar p\u00e5 Stockholm Corporate Finance 15:e Life Science Kapitalmarknadsdagar den 8 &#8211; 9 mars 2023 p\u00e5 IVA konferenscenter i Stockholm. VD Jonas Jarvius presenterar&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-20973","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"_links":{"self":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/mfn_news\/20973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/media?parent=20973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}